Latest news

Daily Snap - 12. September 2025

Daily Snap - 12. September 2025

Joachim Eeckhout
Revolution’s daraxonrasib heads to Phase III after strong PDAC trial results

Revolution’s daraxonrasib heads to Phase III after strong PDAC trial results

Eduardo Longoria
FibroGen pays $1.25M to settle SEC allegations over manipulated roxadustat data

FibroGen pays $1.25M to settle SEC allegations over manipulated roxadustat data

Eduardo Longoria
Daily Snap - 11. September 2025

Daily Snap - 11. September 2025

Joachim Eeckhout
Trump eyes crackdown on U.S. pharma deals with China over security concerns

Trump eyes crackdown on U.S. pharma deals with China over security concerns

Eduardo Longoria
UK life sciences face sharp investment drop as global rivals surge ahead

UK life sciences face sharp investment drop as global rivals surge ahead

Eduardo Longoria
Daily Snap - 10. September 2025

Daily Snap - 10. September 2025

Joachim Eeckhout
Lilly opens its AI vault to biotech startups with TuneLab platform

Lilly opens its AI vault to biotech startups with TuneLab platform

Eduardo Longoria
Novartis bets $1.4B on anti-inflammatory heart drug in Tourmaline buyout

Novartis bets $1.4B on anti-inflammatory heart drug in Tourmaline buyout

Eduardo Longoria
Daily Snap - 9. September 2025

Daily Snap - 9. September 2025

Joachim Eeckhout
NRG Therapeutics raises $67M to target Parkinson’s and ALS through mitochondria

NRG Therapeutics raises $67M to target Parkinson’s and ALS through mitochondria

Eduardo Longoria
BioNTech, BMS aim to upend lung cancer treatment with new bispecific drug

BioNTech, BMS aim to upend lung cancer treatment with new bispecific drug

Eduardo Longoria
FirstBack
12345678
Next Last